ZEMAIRA
Live / Allowed — Second extension granted (statement of use) (as of 18 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Feb 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99036259
- Mark type
- Word mark
- Filed
- 11 Feb 2025
- Published for opposition
- 22 Apr 2025
- Attorney of record
- Scott Woldow
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations to treat deficiencies of Alpha One Proteinase inhibitors; Pharmaceutical preparations for transplant conditions; Pharmaceutical preparations for renal conditions; Pharmaceutical preparations for treatment of rejection in transplant recipients; Pharmaceutical preparations for antibody rejection conditions; Pharmaceutical preparations for treatment of emphysema, lung conditions, anti-inflammatory conditions, immunological conditions, and protein deficiencies; Pharmaceutical preparations to prevent and treat graft vs. host disease; Pharmaceutical preparations for prevention and treatment of Primary Graft Dysfunction
Owner
- CSL Behring L.L.C., King of Prussia, PA, US
- CSL Behring L.L.C., King of Prussia, PA, US
Prior registrations
Prosecution history
- 19 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 May 2026 — SOU EXTENSION 2 GRANTED
- 18 May 2026 — SOU EXTENSION 2 FILED
- 18 May 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Nov 2025 — SOU EXTENSION 1 GRANTED
- 17 Nov 2025 — SOU EXTENSION 1 FILED
- 17 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Apr 2025 — PUBLISHED FOR OPPOSITION
- 16 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Mar 2025 — ASSIGNED TO EXAMINER
- 11 Feb 2025 — APPLICATION FILING RECEIPT MAILED